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ABSTRACT
Background
Trachoma is a leading cause of preventable blindness. Reports from eye surgery camps and
anecdotal data indicated that blinding trachoma is a serious cause of visual impairment in
Mankien payam (district) of southern Sudan. We conducted this study to estimate the
prevalence of trachoma, estimate targets for interventions, and establish a baseline for
monitoring and evaluation.
Methods and Findings
A population-based cross-sectional survey was conducted in May 2005. A two-stage cluster
random sampling with probability proportional to size was used to select the sample
population. Participants were examined for trachoma by experienced graders using the World
Health Organization simplified grading scheme. A total of 3,567 persons were examined (89.7%
of those enumerated) of whom 2,017 were children aged less than 15 y and 1,550 were aged 15
y and above. Prevalence of signs of active trachoma in children aged 1–9 y was: trachomatous
inflammation-follicular (TF)¼57.5% (95% confidence interval [CI], 54.5%–60.4%); trachomatous
inflammation-intense (TI)¼39.8% (95% CI, 36.3%–43.5%); and TF and/or TI (active trachoma)¼
63.3% (95% CI, 60.1%–66.4%). Prevalence of trachomatous trichiasis was 9.6% (95% CI, 8.4%–
10.9%) in all ages, 2.3% (95% CI, 1.6%–3.2%) in children aged under 15 y, and 19.2% (95% CI,
17.0%–21.7%) in adults. Men were equally affected by trichiasis as women: odds ratio ¼ 1.09
(95% CI, 0.81%–1.47%). It is estimated that there are up to 5,344 persons requiring trichiasis
surgery in Mankien payam.
Conclusions
Trachoma is a serious public health problem in Mankien, and the high prevalence of trichiasis
in children underscores the severity of blinding trachoma. There is an urgent need to
implement the surgery, antibiotics, facial cleanliness, and environmental change (SAFE)
strategy for trachoma control in Mankien payam, and the end of the 21-y civil war affords an
opportunity to do this.
The Editors’ Summary of this article follows the references.
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Trachoma is a neglected disease that affects those who live
in the poorest conditions; it causes blindness, disability,
stigmatization, and poverty. Caused by ocular infection with
Chlamydia trachomatis, trachoma is the leading infectious cause
of preventable blindness and is estimated to be responsible
for at least 3.6% of all blindness worldwide [1]. The World
Health Organization (WHO) estimates that active trachoma
affects 84 million persons, and 7.6 million have trichiasis, the
potentially blinding state of the disease, in 55 countries [2].
Blindness due to trachoma is preventable through the WHO-
endorsed strategy of surgery, antibiotics, facial cleanliness
and environmental change (SAFE) [3]. The WHO Alliance for
the Global Elimination of Trachoma (GET 2020) has
identiﬁed Sudan as one of the priority countries to be
targeted for the implementation of the SAFE strategy.
Trachoma has long been known to be prevalent in parts of
Sudan [4]. Recent surveys indicate that trachoma is a severe
public health problem in the states of Eastern Equatoria and
Upper Nile of southern Sudan [5]. Postconﬂict southern
Sudan is characterized by poor or absent health infra-
structure, widespread illiteracy, poor sanitation, lack of
potable water, and extreme poverty, with over 90% of the
population living off less than one dollar a day [6]. In
Mankien payam (district), water is inaccessible most of the
year, there are no latrines, people live in close proximity with
cattle, eye-seeking ﬂies are rampant, and hygiene practices
are poor (The Carter Center, unpublished data). These
factors have contributed to aggravating the trachoma
situation. The prevalence of trachoma in Mankien is not
known. However, during an eye surgery camp in November
2004, it was observed that trachomatous trichiasis (TT) was
very common. Out of 368 patients who received eye surgery
over a 2-wk period, 203 (55.2%) underwent trichiasis surgery
(Christoffel-Blindenmission, unpublished data). As a response
to this anecdotal evidence, we planned a cross-sectional
population-based survey with the broad objective of estimat-
ing the prevalence of active trachoma and TT, and gauging
the need for speciﬁc trachoma control interventions. The
speciﬁc objectives were to: (1) estimate the prevalence of
active trachoma signs in children aged 1–9 y; (2) estimate the
prevalence of TT in persons aged 15 y and above; (3) estimate
targets for trachoma control interventions; and (4) establish
baselines for future monitoring and evaluation.
Methods
Study Site
A population-based cross-sectional study was conducted in
Mankien payam, located in Unity state of southern Sudan in
May 2005. Mankien has an estimated population of 50,000
persons [7]. This area has been severely affected by the 21-y
conﬂict in southern Sudan due to its proximity to the oil
ﬁelds. It comprises four bomas (subdistricts): Tam, Mandul,
Kernyang, and Mankien. The main economic activities are
cattle rearing and subsistence farming, and the Nuer are the
predominant ethnic group.
Sample Population
The sample size was calculated to allow for estimation of at
least 50% prevalence of active trachoma (grades trachoma-
tous inﬂammation-follicular [TF] and/or trachomatous in-
ﬂammation-intense [TI]) in children aged 1–9 y within a
precision of 10% given a 95% conﬁdence limit and a design
effect of 5. We also aimed to estimate at least 2.5% prevalence
of TT in persons aged 15 y and above within a precision of
1.5% at 95% conﬁdence limit and a design effect of 2 [8,9].
Therefore at least 480 children aged 1–9 y and 820 persons
aged 15 y and above were to be examined.
A two-stage cluster random sampling design with proba-
bility proportional to size was used to select the sample. A
cluster was deﬁned as a village. Mankien payam has 73 villages
in four bomas, one of which (Mankien boma, 12 villages) was
inaccessible at the time of the survey due to insecurity and
was therefore excluded from the sampling frame. The
remaining 61 villages were eligible for selection: in the ﬁrst
stage, 22 villages were selected with probability proportional
to the estimated population of the bomas. In the second
stage, 25 households were selected from each village using the
random walk method [10]. The ﬁrst household was randomly
selected by going to the middle of the village and spinning a
pen after which the household nearest to the ball-tip of the
pen was selected. Subsequent households were selected with
the ‘‘next’’ household being deﬁned as the one whose door
was closest. All residents of selected households were
enumerated and those present examined. An attempt was
made to examine absentees by returning to households in
which persons were absent on the day of the survey.
Households in which all residents were not available were
skipped. Due to logistical constraints, it was not possible to
return to the village on a different day to follow up any
absentees.
Trachoma Grading
IECWs (integrated eye care workers) qualiﬁed in using the
WHO simpliﬁed grading system were retrained by an
experienced ophthalmic nurse (F. Ole-Sempele) [11]. This
scheme comprises ﬁve stages: TF, TI, trachomatous scarring
(TS), TT and corneal opacity (CO). Minimum accepted
interobserver agreement was set at 80% and reliability
assessed in two stages. In the ﬁrst stage, trainee examiners
identiﬁed trachoma grades using the WHO set of trachoma
slides [8]. Those examiners who achieved at least 80%
agreement then proceeded to the second stage of ﬁeld
evaluation. During ﬁeld evaluation, a reliability study
comprising 50 persons of varying age and sex were selected
by the ophthalmic nurse to represent all trachoma grades.
Each trainee examiner evaluated all 50 participants inde-
pendently and recorded their ﬁndings on a preprinted form.
Interobserver agreement was then calculated for each trainee
using the ophthalmic nurses’ observation as the ‘‘gold
standard.’’ Only trainees achieving at least 80% interobserver
agreement after the ﬁeld evaluation were included as graders.
All persons living within each selected household who gave
verbal consent were examined using a torch and a 2.53
magnifying binocular loupe. Each eye was examined ﬁrst for
in-turned lashes (TT), and the cornea was then inspected for
COs. The upper conjunctiva was subsequently examined for
inﬂammation (TF and TI) and scarring (TS). Both eyes were
examined. Signs had to be clearly visible in accordance with
the simpliﬁed grading system in order to be considered
present. Alcohol-soaked cotton swabs were used to clean the
examiner’s ﬁngers between examinations. Individuals with
signs of active trachoma (TF and/or TI) were offered treat-
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referred to the health center where free surgery was available.
Quality Control, Data Entry, and Analysis
Data were double entered by different entry clerks and
compared for consistency using EpiInfo version 3.3.2 (Cen-
ters for Disease Control and Prevention [http://www.cdc.gov/
EpiInfo]). Statistical analysis was conducted using Stata
version 8.2 (Stata Corporation [http://www.stata.com]). Pear-
son v
2 was used to assess the age and sex distribution of the
sample population. Conﬁdence intervals (CIs) for the point
estimates were derived using the Huber/White sandwich
estimator of variance to adjust for the clustering effects of
trachoma at the household level [12]. To derive population
estimates of trachoma burden, prevalence of signs of
trachoma were adjusted for age and sex according to the
population structure. The 95% CIs of the adjusted prevalence
estimates were multiplied by the population estimates to
derive the lower and upper bounds of those requiring TT
surgery. Interobserver agreement of trachoma examiners was
assessed using the kappa (j) statistic [13].
Ethical Considerations
The Sudan People’s Liberation Movement Secretariat of
Health (SPLM/Health) approved the protocol, and clearance
to conduct the surveys was obtained from the local author-
ities. Verbal consent to participate was sought from the head
of the household, and from each individual, and the parents
of small children in accordance with the declaration of
Helsinki. Personal identiﬁers were removed from the dataset
before analyses were undertaken.
Results
Sample Population
Twenty-two villages (clusters) were sampled and 529
households visited. The mean household size was 7.5 (Stand-
ard deviation [SD] ¼ 2.5) with household size ranging from
three to 16 persons. A total of 3,567 persons were examined
(89.7% of those enumerated) of whom 2,017 were children
aged less than 15 y and 1,550 were aged 15 y and above. The
mean number of persons examined per team per day was 162
(range, 90–228). There were no differences in the age and sex
distribution among the 409 persons not examined. Most of
the absentees were out at the time of the survey. Of the 3,567
persons included in the analysis, 1,589 (44.5%) were males
and 1,978 (55.5%) were females (Table 1). There were more
females than males aged 15 y and above among persons
examined (Pearson v
2 ¼ 36.5; p ¼ 0.001). The age range was 2
wk to 80 y, with a mean age of 17.6 y (SD ¼ 17.1) and median
age of 11 y (interquartile range, 4–28).
Trachoma Prevalence
The prevalence of active trachoma and trichiasis found in
this study is shown in Table 2, whereas Figures 1 and 2 show
the age- and sex-speciﬁc prevalence of trachoma signs. The
prevalence of TF in children aged 1–9 y was 57.5% (95% CI,
54.5%–60.4%), whereas prevalence of TI in the same age
group was 39.8% (95% CI, 36.3%–43.5%). Active trachoma
(TF and/ or TI) prevalence in children aged 1–9 y was 63.3%
(95% CI, 60.2%–66.4%). There was no sex difference in active
trachoma: odds ratio (OR) ¼ 0.82 (95% CI, 0.66–1.01). The
prevalence of active trachoma signs peaked between age 2
and 3 y and then declined (Figures 1 and 2). In persons aged
Table 1. Demographic Characteristics of the Sample Population
Age Group (Years) Male Female Total
Under 1, n (%) 71 (2.0) 60 (1.7) 131 (3.7)
1–9, n (%) 781 (21.9) 775 (21.7) 1,556 (43.7)
10–14, n (%) 178 (5.0) 152 (4.3) 330 (9.3)
15 and older , n (%) 559 (15.7) 991 (27.8) 1,550 (43.5)
Total, n (%) 1,589 (44.5) 1,978 (55.5) 3,567 (100)
Mean age (SD) 15.3 (16.7) 19.3 (17.3) 17.6 (17.1)
Median age (IQR) 9 (3–21) 15 (5–30) 11 (4–28)
IQR, interquartile range; SD, standard deviation.
doi:10.1371/journal.pmed.0030478.t001
Table 2. Key Trachoma Prevalence Indicators by Gender
Prevalence Indicators Sex Total
Male, n (%) Female, n (%) n (%) 95% CI
TF in children aged 1–9 y 476 (60.9) 419 (54.1) 895 (57.5) 54.5–60.4
TI in children aged 1–9 y 326 (41.7) 394 (37.9) 620 (39.8) 36.3–43.5
TF and/or TI in children aged 1–9 y 516 (66.0) 470 (60.6) 986 (63.4) 60.2–66.4
TT in children aged less than 15 y 18 (1.9) 25 (2.7) 43 (2.3) 1.6–3.2
TT in persons aged 15 y and above 112 (20.1) 186 (18.8) 298 (19.2) 17.0–21.7
doi:10.1371/journal.pmed.0030478.t002
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Trachoma in Southern Sudan10 y and above, there was a marked decline in the prevalence
of active trachoma signs with prevalence of approximately
13% in persons aged 30 y and above (Figure 1).
The overall prevalence of TS was 19.8% (95% CI, 18.0%–
21.7%). TS was found in 11.5% (95% CI, 9.9%–13.4%) of
persons aged less than 15 y, and 30.5% (95% CI, 27.6%–
33.5%) of persons aged 15 y and above. TS prevalence
increased gradually with age (Figure 1) and there was some
evidence that females were more likely to have TS compared
to males, although this was not statistically signiﬁcant: p ¼
0.125; OR ¼ 1.19 (95% CI, 0.95–1.50). The overall prevalence
of TT in the sample population was 9.6%; (95% CI, 8.4%–
10.9%). The prevalence of TT in children aged less than 15 y
was 2.3% (95% CI, 1.6%–3.2%), with trichiasis observed in a
child aged 4 y. TT prevalence in persons aged 15 y and above
was 19.2% (95% CI, 17.0%–21.7%). There was no sex
difference in the prevalence of TT (OR ¼ 1.08; 95% CI,
0.80–1.46). Prevalence of TT increased with age (Figure 1).
Prevalence of TF in children aged 1–9 y and TT in persons
aged 15 y and above varied between villages, ranging from
14.0% to 62.7% and 1.7% to 23.3%, respectively.
Trachoma-related CO was found in 7.3% (95% CI, 6.5%–
8.2%) of the sample population (Table 3). Consistent with the
ﬁndings for TT, prevalence of CO increased with age (Figure
1). There was no sex difference in the prevalence of CO: OR¼
1.17 (95% CI, 0.82–1.67). The prevalence of bilateral CO (CO
in both eyes) was 3.1% (95% CI, 2.7%–3.6%). This represents
the proportion of the sample population that was visually
impaired due to trachoma. Interobserver agreement among
examiners who participated in the study compared to our
standard (F. Ole-Sempele) ranged from 88% to 98%; overall
kappa¼0.64. Kappa for individual trachoma grades was: TF¼
0.54, TI ¼ 0.53, TS ¼ 0.50, TT ¼ 0.88, and CO ¼ 0.89.
Trachoma Burden
Estimates of trachoma burden and projected targets for
trachoma control interventions are summarized in Table 4.
The number of persons with signs of active trachoma in
Mankien payam was estimated at 18,417 (lower and upper
bounds ¼ 17,354–19,513), whereas the estimated number of
persons with TT was 4,557 (lower and upper bounds¼3,946–
5,344). CO was estimated to affect 2,799 (lower and upper
bounds ¼ 2,268–3,451) persons, of whom 1,354 (lower and
upper bounds ¼ 1,038–1,759) had bilateral CO. For planning
purposes, the number of persons requiring corrective
trichiasis surgery was estimated at 5,344, whereas up to
1,759 persons required rehabilitation for various levels of loss
of vision due to trachoma.
Discussion
This population-based survey provides some of the ﬁrst
reliable data on the prevalence of trachoma in Unity state of
southern Sudan, and conﬁrms the initial reports that
trachoma is a severe public health problem in Mankien
payam. With peace now in place in southern Sudan, these
data will be important in establishing health priorities. More
than half of children aged 1–9 y had TF (57.5%), whereas TI
was present in two ﬁfths (39.8%). The population estimate for
prevalence of TT was 9.6% with a ﬁfth (19.2%) of persons
aged 15 y and above having this blinding form of trachoma.
An exceptionally high prevalence of TT of 2.3% was found in
children aged less than 15 y, which suggests intense trans-
mission in early childhood. The overall prevalence of
trachoma-related bilateral corneal opacity of 3.1% was
alarming. From these data, we estimate that trichiasis surgery
is indicated for up to 5,344 persons in Mankien, whereas the
entire study population of 50,000 is in need of mass treatment
with antibiotics, health education, and environmental im-
provements to reduce the likelihood of transmission.
We used a two-stage cluster random sampling design to
select our sample. This sampling method is practical,
efﬁcient, and well suited for populations in which reliable
population census data are not available. The random walk
Figure 1. Age and Sex Distribution of Trachoma Signs (All Ages)
doi:10.1371/journal.pmed.0030478.g001
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Trachoma in Southern Sudanmethod was used to select households. This method may have
introduced bias causing overestimation or underestimation
of trachoma prevalence at the individual village level, but is
likely to have affected the overall prevalence estimates to a
lesser extent because these were calculated from 22 villages
[14]. Two other methods have been suggested for trachoma
assessment: Trachoma Rapid Assessment (TRA) [15] and
Assurance Sampling Trachoma Rapid Assessment (ASTRA)
[16]. TRA has major limitations: it utilizes a convenience
sample, does not allow for estimation of prevalence, and has
been found to be inconsistent; and its accuracy is doubtful
[17]. ASTRA is based on Lot Quality Assurance Sampling
(LQAS) and is recommended for rapid assessment of
prevalence of active trachoma. ASTRA has a key advantage
of using small sample sizes; however, it is not practical in
settings like southern Sudan where up-to-date population
census data are not available to generate a stratiﬁed random
sample. Another drawback is that ASTRA recommends
sampling children aged 2–5 y, and thus does not comply
with the WHO guidelines of estimating active trachoma
prevalence in children aged 1–9 y [18]. In addition, ASTRA
does not provide for estimation of prevalence of chronic
signs (TS, TT, and CO) and is therefore of limited use in
comprehensive assessment of trachoma prevalence.
A response rate of 89.7% was achieved, which was adequate
to meet the study objectives and satisfactory, given the
logistical and practical constraints of conducting a survey in a
postconﬂict environment. Most of the absentees were aged 15
y and above; therefore, this undersampling of adults is likely
to have overestimated the prevalence of TT because
absentees were more likely not to have TT compared to
persons present. There were no age or sex differences in
persons not examined; however, the proportion of males aged
15 y and above was less than of females. This is probably a
reﬂection of the prolonged civil war which has resulted in
excess mortality and out-migration of males aged 15–50 y.
Mankien boma (12 villages) was excluded from the sampling
frame due to insecurity and inaccessibility. Although this is a
potential source of bias, we do not expect this to have
affected the validity of this survey given the homogenous
nature of the payam and the risk factors that predispose these
communities to trachoma. Trachoma grading was not
supported by nucleic acid ampliﬁcation techniques, which
can detect the presence of C. trachomatis DNA or RNA with
great sensitivity and speciﬁcity [19]. However, nucleic acid
ampliﬁcation techniques are not routinely used operationally
by any program due to the stringent requirements to prevent
contamination of samples and the prohibitive cost of
processing. Clinical signs are at present the prime basis for
program planning and evaluation [20].
The WHO has suggested two key prevalence indicators for
determining the public health importance of blinding
Figure 2. Age and Sex Distribution of Active Trachoma Signs in Children Aged 1–9 y
doi:10.1371/journal.pmed.0030478.g002
Table 3. Prevalence of Trachomatous CO (All Ages)
CO Sex Total
Male, n (%) Female, n (%) n (%) 95% CI
Unilateral (one eye) 96 (6.0) 164 (8.3) 260 (7.3) 6.5–8.2
Bilateral (both eyes) 38 (2.4) 73 (3.7) 111 (3.1) 2.7–3.6
doi:10.1371/journal.pmed.0030478.t003
PLoS Medicine | www.plosmedicine.org December 2006 | Volume 3 | Issue 12 | e478 2428
Trachoma in Southern Sudantrachoma: TF prevalence of 10% or more in children aged 1–
9 y, and TT prevalence of 1% or more in persons aged 15 y
and above [18]. Prevalence of TF and TT revealed in this
study exceeds the WHO parameters with TF prevalence being
over ﬁve times and TT prevalence nearly 20 times. The
pattern of signs of trachoma is consistent with ﬁndings from
other parts of southern Sudan [5,21]. Similar pattern of active
trachoma has been observed in Ethiopia, Tanzania, and Mali
[22–24]. However, the prevalence of TT in children observed
in this study by far exceeds that recorded in other trachoma
hyper-endemic settings (e.g., Ethiopia less than 1%, Tanzania
¼ 0.1%) [22,23,25]. The severity of blinding trachoma in this
population is further underscored by its early onset and rapid
p r o g r e s s i o n .A m o n g1 3 1i n f a n t s( a g e2w kt o1 1m o )
examined, 73 (55.7%) had signs of active trachoma. This
early onset coupled with high prevalence of active trachoma
in children is consistent with the observed prevalence of
scarring. The high prevalence of TS in younger age groups is
likely to be as a result of very intense transmission of C.
trachomatis and frequent reinfection. This predicts a high
prevalence of TT among children and adults with the
concomitant risk of blindness early in life; and is well
supported by the observed prevalence of TT of 2.3% in
children aged less than 15 y. A similar pattern of TT in
children has been documented in other parts of southern
Sudan [5]. This pattern of trichiasis in children is predictive
of a massive future burden of blindness due to trachoma and
calls for urgent measures for trachoma control. Therefore,
although prevalence of TT in children aged less than 15 y is
not a prevalence indicator within the existing WHO guide-
lines, age-speciﬁc prevalence of TT in young children may be
a valuable extension of the WHO prevalence indicators. The
prevalence of TT in persons aged 15 y and above was 19.2%.
Contrary to the usual pattern in which women are two to four
times more likely than men to have TT, there was no sex
difference observed in this population. This sex equality of
suffering from trichiasis may partly be explained by the
atypical age–sex structure in this population; however, this
phenomenon merits further investigation.
All the communities in Mankien payam are in dire need of
trachoma control interventions. Although resources will
undoubtedly be inadequate to immediately provide surgery
for all, priority might be given to children and those with
some residual vision, since that gives the best chance of saving
years of useful sight. Mass treatment of communities with
azithromycin should be targeted to the entire population of
Mankien payam. During the survey, we observed poor facial
hygiene in children, many ﬂies on children’s faces, and a lack
of sanitation and water—all of which are risk factors for
trachoma. These observations highlight the need for facial
cleanliness and environmental change interventions in these
communities. Achieving sustained changes in personal and
community hygiene will be a challenge to the implementation
of the SAFE strategy, but immediate gains can be made by
incorporating hygiene education into the curriculum for the
new schools and promoting appropriate disposal of human
feces.
In conclusion, Mankien payam has trachoma of severe
public health magnitude, and there is an urgent need to
implement the full SAFE strategy for trachoma control in this
population. The end of the conﬂict affords a great oppor-
tunity for rapid improvements in health infrastructure,
access to health care, and implementation of village-based
primary health care services in southern Sudan. Although
attention will certainly be focused on the ‘‘big three’’
diseases—malaria, HIV/AIDS, and tuberculosis—neglected
diseases such as trachoma, Guinea worm [26], and oncho-
cerciasis [27] are all highly prevalent in southern Sudan. It
should be possible to integrate control of these neglected
diseases into the structure of the new health system and
empower this most disadvantaged population to move into
the postconﬂict phase with a greatly reduced burden of
preventable diseases.
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Editors’ Summary
Background. Trachoma is an infectious disease that it is cased by a
bacterium, Chlamydia trachomatis. The infection can be passed from one
person to another through contact with hands and clothes, and by flies.
The disease develops gradually—while children are most susceptible to
infection, they may not note its effects until adulthood, when scarring
from repeated infections causes the eyelashes to turn inward
(‘‘trichiasis’’). The cornea—the transparent front part of the eye—
becomes damaged by the eyelashes and develops ulcers, and eventually
blindness results. Trachoma is most common in poor rural communities
living in overcrowded conditions with limited access to water and health
care. As improved living conditions, better hygiene, and early treatment
of the infection with antibiotics can prevent the disease—and surgery for
trichiasis is very effective—trachoma is regarded as a preventable type of
blindness. It is also described as a ‘‘neglected disease’’; over seven
million people have trichiasis and it causes an estimated 3.6% of the
world’s blindness, but it does not receive the attention that such a
widespread and serious condition demands. The World Health Organ-
ization recommends a strategy for trachoma control known as SAFE—
surgery, antibiotics, facial cleanliness, and environmental change.
Why Was This Study Done? The environment and living conditions in
the southern Sudan are such that trachoma is likely to be common;
there have been reports that this is the case, but reliable information
has not been available. In part, this is because of the serious conflict in
the country that lasted many years. In 2005 when the region became
more peaceful, planning began in order to expand health programmes
there. Good planning must be based on reliable information as to how
many people are affected by different health conditions, including
trachoma.
What Did the Researchers Do and Find? They focused on just one
district of southern Sudan (Mankien), where they also conducted a
survey that looked for all types of blindness. They selected 22 villages at
random and sent people to conduct the survey who were experienced in
recognizing trachoma and in using the WHO’s system for grading the
various stages of the disease, from early infection to blindness. Once in
the village, the survey teams selected homes at random and examined
the people there. A total of 3,567 people were examined, of whom 2,017
were children aged less than 15 years. The earliest stages of infection
were very common indeed, particularly in children aged 1–9, over half of
whom had some sign of infection. In adults, one in five had trichiasis
caused by trachoma.
What Do These Findings Mean? The very high proportion of children
with early stages of trachoma is of great concern and, based on the
survey, over 5,000 people in Mankien are estimated to be in need of
trichiasis surgery. The survey suggests that other parts of the southern
Sudan are also likely to have similar problems. This is a particularly
disturbing situation for a disease that should be very easy to prevent.
Antibiotic treatment and preventive measures are also needed. The SAFE
strategy must be urgently put into action. Further discussion of the
implications of this study and of the methods the researchers used are
found in two ‘‘Perspective’’ articles in this issue of PLoS Medicine (by
Buchan and by Kuper and Gilbert).
Additional Information. Please access these Web sites via the online
version of this summary at http://dx.doi.org/10.1371/journal.pmed.
0030478.
  Basic information on trachoma may be found on Wikipedia, an
internet encyclopaedia that anyone can edit
  More detailed information is available from the International
Trachoma Initiative and Medline Plus
  The Carter Center implements trachoma control activities in Africa
  The SAFE strategy is described in detail in a document available on the
Web site of the Carter Center
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